| 摘要 |
<p>The invention relates to a method for the treatment or prophylaxis of glutamate- and/or calcium-induced disorders which comprises administering a therapeutically active amount of at least one compound selected from the group consisting of α-tocotrienol, β-tocotrienol, η-tocotrienol and δ-tocotrienol and their derivatives.</p> |
